Cargando…
Antifungal activity of MAF-1A peptide against Candida albicans
Invasive candidiasis is a major threat to human health, and Candida albicans is the most common pathogenic species responsible for this condition. The incidence of drug-resistant strains of C. albicans is rising, necessitating the development of new antifungal drugs. Antimicrobial peptides (AMPs) ha...
Autores principales: | Cheng, Rong, Xu, Qiang, Hu, Fangfang, Li, Hongling, Yang, Bin, Duan, Zonggang, Zhang, Kai, Wu, Jianwei, Li, Wei, Luo, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046747/ https://www.ncbi.nlm.nih.gov/pubmed/33452940 http://dx.doi.org/10.1007/s10123-021-00159-z |
Ejemplares similares
-
Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A
por: Cheng, Rong, et al.
Publicado: (2020) -
Transcriptional Responses of Candida albicans to Antimicrobial Peptide MAF-1A
por: Wang, Tao, et al.
Publicado: (2017) -
Antifungal Efficacy of Antimicrobial Peptide Octominin II against Candida albicans
por: Jayasinghe, J. N. C., et al.
Publicado: (2023) -
In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023) -
Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
por: Bezerra, Leandro P., et al.
Publicado: (2022)